Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Shingleton, JR; Dave, SS

Published Date

  • January 10, 2020

Published In

Volume / Issue

  • 38 / 2

Start / End Page

  • 166 - 168

PubMed ID

  • 31770050

Pubmed Central ID

  • 31770050

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Digital Object Identifier (DOI)

  • 10.1200/JCO.19.02587

Language

  • eng

Conference Location

  • United States